image
Healthcare - Biotechnology - NASDAQ - US
$ 60.48
-2.04 %
$ 3.82 B
Market Cap
-13.94
P/E
Price Target Average
10.23%
Revenue Forecast Estimate
85.75%
EBIT Estimate
--36.79%
Net Income Estimate
46.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Rhythm Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for RYTM of $66.7 , with forecasts ranging from a low of $55 to a high of $80 .
RYTM Lowest Price Target Wall Street Target
55 USD -9.06%
RYTM Average Price Target Wall Street Target
66.7 USD 10.23%
RYTM Highest Price Target Wall Street Target
80 USD 32.28%
Price
Max Price Target
Min Price Target
Average Price Target
8080757570706565606055555050454540403535Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart RYTM

image
$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.020202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RYTM

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)($700.0m)($700.0m)($800.0m)($800.0m)($900.0m)($900.0m)($1.0b)($1.0b)20202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RYTM

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)20202020202120212022202220232023202420242025202520262026202720272028202820292029